home / stock / avxl / avxl quote
Last: | $4.55 |
---|---|
Change Percent: | -1.33% |
Open: | $4.56 |
Close: | $4.55 |
High: | $4.66 |
Low: | $4.43 |
Volume: | 942,702 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.55 | $4.56 | $4.55 | $4.66 | $4.43 | 942,702 | 05-17-2024 |
$4.5 | $4.55 | $4.5 | $4.67 | $4.435 | 880,149 | 05-16-2024 |
$4.49 | $4.45 | $4.49 | $4.5889 | $4.4 | 1,472,659 | 05-15-2024 |
$4.31 | $4.04 | $4.31 | $4.4599 | $4.03 | 1,447,361 | 05-14-2024 |
$3.99 | $3.85 | $3.99 | $4.26 | $3.85 | 1,105,719 | 05-13-2024 |
$3.81 | $3.88 | $3.81 | $3.9199 | $3.745 | 887,093 | 05-10-2024 |
$3.88 | $3.72 | $3.88 | $3.93 | $3.58 | 1,001,710 | 05-09-2024 |
$3.71 | $3.76 | $3.71 | $3.795 | $3.65 | 1,009,932 | 05-08-2024 |
$3.84 | $3.86 | $3.84 | $3.95 | $3.7602 | 876,789 | 05-07-2024 |
$3.84 | $3.87 | $3.84 | $3.87 | $3.76 | 672,936 | 05-06-2024 |
$3.85 | $3.89 | $3.85 | $3.98 | $3.82 | 872,311 | 05-03-2024 |
$3.76 | $3.73 | $3.76 | $3.77 | $3.625 | 743,329 | 05-02-2024 |
$3.69 | $3.66 | $3.69 | $3.85 | $3.53 | 1,434,796 | 05-01-2024 |
$3.65 | $3.6 | $3.65 | $3.745 | $3.54 | 882,438 | 04-30-2024 |
$3.65 | $3.42 | $3.65 | $3.745 | $3.41 | 1,161,530 | 04-29-2024 |
$3.44 | $3.4 | $3.44 | $3.48 | $3.37 | 949,972 | 04-26-2024 |
$3.39 | $3.38 | $3.39 | $3.465 | $3.25 | 1,272,866 | 04-25-2024 |
$3.41 | $3.71 | $3.41 | $3.8 | $3.39 | 1,950,026 | 04-24-2024 |
$3.68 | $3.69 | $3.68 | $3.91 | $3.67 | 1,359,315 | 04-23-2024 |
$3.68 | $3.85 | $3.68 | $3.85 | $3.64 | 1,358,524 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain inv...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceuti...